canakinumab
pharmaceutical drug
Facts
9 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound[2]
- Has use
- medication[3]
- Active ingredient in
- Ilaris[7]
- Defined daily dose
- +2.7[8]
- Has characteristic
- biopharmaceutical[4]
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*[9]
- Subject has role
- monoclonal antibody[6]
- World Health Organisation international non-proprietary name
- canakinumab[5]
🏷️ Also known as
en ACZ-885
en ACZ885
en canakinumab
en Ilaris
ar كاناكينوماب
fa کاناکینومب
id Kanakinumab
it Ilaris
ja カナキヌマブ
pt Canaquinumabe
ru Канакинумаб
uk Канакінумаб
zh 卡納單抗
🔖 Identifiers · 16
- OpenAlex ID
- C2779725882
- ATC code
- L04AC08
- CAS Registry Number
- 914613-48-2
- ChEMBL ID
- CHEMBL1201834
- DrugBank ID
- DB06168
- Freebase ID
- /m/02vrcld
- Guide to Pharmacology Ligand ID
- 6773
- KEGG ID
- D09315
- LiverTox ID
- Canakinumab
- MeSH descriptor ID
- C541220
- Microsoft Academic ID (discontinued)
- 2779725882
- NDF-RT ID
- N0000178497
Show all 16 identifiers +4
- RxNorm CUI
- 853491
- UNII
- 37CQ2C7X93
- WikiProjectMed ID
- Canakinumab
- World Health Organisation international non-proprietary name numeric ID
- 8836
🔗 Connections
Has characteristic 1
Has use 1
Subclass of 1
Subject has role 1
← Drug or therapy used for treatment 1
Press Enter · cited answer in seconds
0 sources
Summary
canakinumab is a type of chemical entity[1].